Bruce Morland

Author PubWeight™ 15.68^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.	J Med Genet	2011	2.52
2	Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.	Lancet Oncol	2013	1.58
3	Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.	N Engl J Med	2009	1.42
4	Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium.	Eur J Cancer	2009	1.26
5	Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors.	Neuro Oncol	2010	1.22
6	Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.	J Clin Oncol	2006	1.15
7	Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.	Eur J Cancer	2012	1.06
8	UK Guidelines for the Management of Bone Sarcomas.	Sarcoma	2010	0.98
9	A genome-wide association study identifies susceptibility loci for Wilms tumor.	Nat Genet	2012	0.97
10	Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group.	J Clin Oncol	2007	0.93
11	Is the European pediatric medicine regulation working for children and adolescents with cancer?	Clin Cancer Res	2013	0.84
12	A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: a European cooperation of the Société Française d'Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG).	Eur J Cancer	2008	0.82
13	The role of the 'innovative therapies for children with cancer' (ITCC) European consortium.	Cancer Treat Rev	2010	0.82
14	Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).	Eur J Cancer	2012	0.81
15	Clinical outcome in children and adolescents with Hodgkin lymphoma after treatment with chemotherapy alone - the results of the United Kingdom HD3 national cohort trial.	Eur J Cancer	2011	0.75
16	Paediatric thoracic tumours presenting as empyema.	Pediatr Surg Int	2006	0.75
17	New drug development in childhood cancer.	Curr Opin Pediatr	2014	0.75
18	Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.	Br J Haematol	2014	0.75